Cell Therapy

UK pharma group acquires Belgium's EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive advocate for the development of rare-disease drugs.

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's still too early to say whether the treatment works in the long term.

Obecabtagene autoleucel has no requirement for a REMS program

Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5%

Patient achieves remission with biologic agent currently used for myeloma

Durable response possible with treatment targeting a different antigen

In a health breakthrough, scientists at the UC Davis Comprehensive Cancer Center in Sacramento, California, have identified a protein on the CD95 receptor that can "program" cancer dells to die.

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

Promising results from small case studies and early clinical trials hint at the potential of CAR-T cell therapy to treat -- and possibly cure -- autoimmune diseases like lupus.

Pediatric patients receiving a donor stem cell transplant who have healthier pretransplant gut microbiota diversity show improved rates of survival and a lower risk of acute GvHD.

CAR–T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.

Advancements in cancer therapy are increasing survival rates and offering hope for a cure to more people.

Granata family's philanthropic gift, which establishes a new endowed fund at AHN, will support the network's Peritoneal Surgery Program

Cancer therapies are getting better and better.

Imec is developing tools and modules with the goals of advancing cancer treatment, sequencing proteomes and better understanding the brain.

From synthetic biology to xenotransplantation, biotech will continue to march forward in 2023, in part powered by data and AI.

A young girl entered remission after receiving an experimental cancer treatment.

New drugs give physicians more options, but bad news for a prior accelerated approval

Antibiotics are standard treatments for fighting dangerous bacterial infections. Yet the number of bacteria developing a resistance to antibiotics is increasing. Researchers from Texas A&M University and the University of São Paulo are overcoming this resistance with light.